MSc Cancer Therapies in Glasgow United Kingdom | University of Strathclyde

University of Strathclyde | Glasgow United Kingdom
Visit institution website for more information
Qualification
Masters Degree (Taught)
Languages
English
Delivery Mode
On-Campus
Tuition (2025)
GBP 31,250
(c. USD41,695.31)
Attendance
Full-time
Full-time Duration
12 months

The UK's only MSc in Cancer Therapies offers a distinctive multidisciplinary approach, blending cancer biology, drug development, formulation science, and radiation biology. This program provides comprehensive insights into the practical, ethical, and economic aspects of personalized cancer treatment, designed for graduates pursuing expertise across the spectrum of cancer therapy development. You'll learn within Strathclyde's renowned Institute of Pharmacy & Biomedical Sciences, home to exceptional radiobiology facilities and the unique Cancer Research UK Drug Formulation Unit. The program is delivered by leading researchers engaged in cutting-edge basic, translational, and clinical cancer research across biomedical and physical sciences. This forward-thinking curriculum prepares graduates to make significant contributions to global cancer treatment advancements through research, education, and various professional sectors.
Program Highlights
Our MSc Cancer Therapies develops your ability to critically evaluate current and emerging treatments, including the complete drug discovery process from target identification to clinical trials. The program combines specialized research training with career-focused skill development, addressing the increasing need from academic, industrial, and healthcare sectors for professionals with expertise in contemporary cancer therapies. The multidisciplinary curriculum ensures comprehensive coverage of this vital field. Upon completion, you will:possess practical knowledge across biological, physical, and radiobiological disciplines crucial for careers in cancer therapy development
understand fundamental principles of cancer drug development, with applications extending to other therapeutic areas
demonstrate capability to conduct independent research meeting publication standards
acquire distinctive skills valuable to pharmaceutical and healthcare industries
be prepared for progression to PhD-level research
The program equips you with both transferable professional skills and specialized expertise in:global perspectives on personalized cancer medicine
radiotherapy applications in diagnosis and combination therapies
current and emerging radiotherapy technologies, nuclear medicine, and radiopharmaceuticals
drug discovery challenges, formulation, and delivery systems, including:
anti-cancer agent development opportunities
medicinal chemistry approaches
screening methodologies
advanced assay techniques
Career Opportunities:
Graduates are prepared for diverse career pathways including:clinical research positions
research roles in pharmaceutical and biotech industries
laboratory technical support positions
specialized sales in medical, pharmaceutical, and life science sectors
charity funding and research support roles
medical writing, patents, and ethics-related careers
academic research and teaching (with potential PhD progression)


Destination of Study

Subjects of Study

Language Requirements

English
IELTS 6.0

Qualification Requirements

Academic requirements/experience
Minimum second-class (2.2) Honours degree, or international equivalent in a science or health-related subject
Students with alternative entry standards or professional experience may also be considered and are usually admitted in the first instance to the Diploma course. Upon satisfactory completion of all Semester 1 assessment, these students will be offered the chance to transfer to the MSc programme.

IELTS - 6.0 overall (no individual band less than 5.5)
TOEFL ibt - 73 overall, with the following minimum scores in each component- (Listening- 17 Reading- 18 Speaking- 20 Writing- 18)

Tuition GBP 31,250

Similar programs for you